Autoimmune pancerebellitis associated with pembrolizumab therapy.
Publication
, Journal Article
Vitt, JR; Kreple, C; Mahmood, N; Dickerson, E; Lopez, GY; Richie, MB
Published in: Neurology
July 10, 2018
Duke Scholars
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
July 10, 2018
Volume
91
Issue
2
Start / End Page
91 / 93
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Methylprednisolone
- Male
- Humans
- Cerebellar Ataxia
- Autoimmune Diseases
- Antibodies, Monoclonal, Humanized
- Aged
- 3209 Neurosciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vitt, J. R., Kreple, C., Mahmood, N., Dickerson, E., Lopez, G. Y., & Richie, M. B. (2018). Autoimmune pancerebellitis associated with pembrolizumab therapy. Neurology, 91(2), 91–93. https://doi.org/10.1212/WNL.0000000000005781
Vitt, Jeffrey R., Collin Kreple, Nausheen Mahmood, Elliot Dickerson, Giselle Y. Lopez, and Megan B. Richie. “Autoimmune pancerebellitis associated with pembrolizumab therapy.” Neurology 91, no. 2 (July 10, 2018): 91–93. https://doi.org/10.1212/WNL.0000000000005781.
Vitt JR, Kreple C, Mahmood N, Dickerson E, Lopez GY, Richie MB. Autoimmune pancerebellitis associated with pembrolizumab therapy. Neurology. 2018 Jul 10;91(2):91–3.
Vitt, Jeffrey R., et al. “Autoimmune pancerebellitis associated with pembrolizumab therapy.” Neurology, vol. 91, no. 2, July 2018, pp. 91–93. Pubmed, doi:10.1212/WNL.0000000000005781.
Vitt JR, Kreple C, Mahmood N, Dickerson E, Lopez GY, Richie MB. Autoimmune pancerebellitis associated with pembrolizumab therapy. Neurology. 2018 Jul 10;91(2):91–93.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
July 10, 2018
Volume
91
Issue
2
Start / End Page
91 / 93
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Methylprednisolone
- Male
- Humans
- Cerebellar Ataxia
- Autoimmune Diseases
- Antibodies, Monoclonal, Humanized
- Aged
- 3209 Neurosciences
- 3202 Clinical sciences